On Sep 9, 2021 Blue Note Therapeutics closed a Series A round and raised $5,200,000 from Alumni Ventures Group, Jazz Venture Partners, Memorial Sloan – […]
Venture Round – Haemalogix
On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management. […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Venture Round – Haemalogix
On Sep 8, 2021 Haemalogix closed a Venture – Series Unknown round and raised A$10,000,000 from Platinum Asset Management, featuring lead investors Platinum Asset Management. […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
Series B – ADARx Pharmaceuticals
On Sep 8, 2021 ADARx Pharmaceuticals closed a Series B round and raised $75,000,000 from Lilly Asia Ventures, OrbiMed, Sirona Capital, SR One, featuring lead […]
Funding Round – Altoida, Inc.
On Sep 8, 2021 Altoida, Inc. closed a Funding Round round and raised $498,335 from Alzheimer’s Drug Discovery Foundation, featuring lead investors Alzheimer’s Drug Discovery […]
Series E – Emulate
On Sep 7, 2021 Emulate closed a Series E round and raised $82,000,000 from Northpond Ventures, Perceptive Advisors, featuring lead investors Northpond Ventures. About the […]
Post-IPO Equity – Adaptimmune
On Sep 7, 2021 Adaptimmune closed a Post-IPO Equity round and raised $150,000,000 from Genentech, featuring lead investors Genentech. About the company: Adaptimmune is located […]
